Yi‐Wu Yuan

640 total citations
22 papers, 477 citations indexed

About

Yi‐Wu Yuan is a scholar working on Molecular Biology, Cancer Research and Biotechnology. According to data from OpenAlex, Yi‐Wu Yuan has authored 22 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Cancer Research and 7 papers in Biotechnology. Recurrent topics in Yi‐Wu Yuan's work include Cancer Research and Treatments (7 papers), RNA modifications and cancer (7 papers) and Epigenetics and DNA Methylation (5 papers). Yi‐Wu Yuan is often cited by papers focused on Cancer Research and Treatments (7 papers), RNA modifications and cancer (7 papers) and Epigenetics and DNA Methylation (5 papers). Yi‐Wu Yuan collaborates with scholars based in China and United States. Yi‐Wu Yuan's co-authors include Liqiang Zhou, Chuan Liu, Xin Lin, Fei Zeng, Qi Zhou, You Wu, Jinliang Wang, Shihao Li, Xin Lin and Hao Lu and has published in prestigious journals such as Experimental Cell Research, Journal of Cellular Physiology and International Journal of Biological Macromolecules.

In The Last Decade

Yi‐Wu Yuan

21 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi‐Wu Yuan China 11 363 306 74 58 53 22 477
Nanhong Tang China 11 211 0.6× 173 0.6× 80 1.1× 102 1.8× 40 0.8× 18 391
Chengyong Lei China 11 294 0.8× 136 0.4× 40 0.5× 94 1.6× 74 1.4× 18 433
Yuanchang Hu China 9 379 1.0× 221 0.7× 50 0.7× 71 1.2× 35 0.7× 14 502
Jong‐Ho Lee South Korea 8 203 0.6× 118 0.4× 103 1.4× 120 2.1× 40 0.8× 12 380
Komal Qureshi-Baig Luxembourg 7 260 0.7× 225 0.7× 36 0.5× 152 2.6× 31 0.6× 7 430
Jing Cui China 13 213 0.6× 152 0.5× 28 0.4× 88 1.5× 35 0.7× 19 328
Jinsei Miyoshi Japan 8 312 0.9× 196 0.6× 35 0.5× 76 1.3× 46 0.9× 17 434
Shaoyong Peng China 13 193 0.5× 161 0.5× 57 0.8× 159 2.7× 64 1.2× 24 437
Huixia Huang China 7 222 0.6× 175 0.6× 72 1.0× 96 1.7× 58 1.1× 15 369

Countries citing papers authored by Yi‐Wu Yuan

Since Specialization
Citations

This map shows the geographic impact of Yi‐Wu Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Wu Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Wu Yuan more than expected).

Fields of papers citing papers by Yi‐Wu Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi‐Wu Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Wu Yuan. The network helps show where Yi‐Wu Yuan may publish in the future.

Co-authorship network of co-authors of Yi‐Wu Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Yi‐Wu Yuan. A scholar is included among the top collaborators of Yi‐Wu Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi‐Wu Yuan. Yi‐Wu Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yuan, Yi‐Wu, et al.. (2025). TFAP4 Regulation of MCM5 Activates the PI3K/AKT Pathway to Promote Invasion and Metastasis of Gastric Cancer. Digestive Diseases and Sciences. 70(4). 1411–1427.
2.
Yuan, Yi‐Wu, et al.. (2024). The Role of Methionine Restriction in Gastric Cancer: A Summary of Mechanisms and a Discussion on Tumor Heterogeneity. Biomolecules. 14(2). 161–161. 2 indexed citations
3.
Lin, Xin, Zhiyang Liu, Chenxi Liu, et al.. (2024). KLF10/CBS increases the sensitivity of gastric carcinoma cells to methionine restriction by promoting sulfur transfer pathway. Experimental Cell Research. 437(1). 114007–114007. 1 indexed citations
4.
Yuan, Yi‐Wu, et al.. (2024). Ferroptosis and its current progress in gastric cancer. Frontiers in Cell and Developmental Biology. 12. 1289335–1289335. 6 indexed citations
5.
Zhou, Qi, Yi‐Wu Yuan, Lu Hao, et al.. (2023). Cancer functional states-based molecular subtypes of gastric cancer. Journal of Translational Medicine. 21(1). 80–80. 7 indexed citations
6.
Li, Yifan, Chenxi Liu, Xin Lin, et al.. (2023). Upregulation of E-cadherin by the combination of methionine restriction and HDAC2 intervention for inhibiting gastric carcinoma metastasis. Acta Biochimica et Biophysica Sinica. 56(1). 62–70. 5 indexed citations
7.
Yuan, Yi‐Wu, Chenxi Liu, Jie Sheng, et al.. (2023). Methionine restriction attenuates the migration and invasion of gastric cancer cells by inhibiting nuclear p65 translocation through TRIM47. Biological Chemistry. 405(4). 257–265. 5 indexed citations
8.
Liu, Chuan, et al.. (2022). Methionine restriction enhances the chemotherapeutic sensitivity of colorectal cancer stem cells by miR-320d/c-Myc axis. Molecular and Cellular Biochemistry. 477(7). 2001–2013. 15 indexed citations
9.
Lin, Xin, Hao Lu, Chuan Liu, et al.. (2021). Methionine deficiency promoted mitophagy via lncRNA PVT1-mediated promoter demethylation of BNIP3 in gastric cancer. The International Journal of Biochemistry & Cell Biology. 141. 106100–106100. 23 indexed citations
10.
Zhou, Liqiang, Hao Lü, Fei Zeng, et al.. (2021). Constructing a new prognostic signature of gastric cancer based on multiple data sets. Bioengineered. 12(1). 2820–2835. 21 indexed citations
11.
Lin, Xin, Liqiang Zhou, Chuan Liu, et al.. (2021). Transfer of LncRNA CRNDE in TAM‐derived exosomes is linked with cisplatin resistance in gastric cancer. EMBO Reports. 22(12). e52124–e52124. 87 indexed citations
12.
Lin, Xin, You Wu, Chuan Liu, et al.. (2021). Exosome-mediated transfer of lncRNA HCG18 promotes M2 macrophage polarization in gastric cancer. Molecular Immunology. 140. 196–205. 68 indexed citations
13.
Yuan, Yi‐Wu, et al.. (2020). Preparation of Internalizing RGD-Modified Recombinant Methioninase Exosome Active Targeting Vector and Antitumor Effect Evaluation. Digestive Diseases and Sciences. 66(4). 1045–1053. 30 indexed citations
14.
Zhou, Liqiang, You Wu, Xin Lin, et al.. (2020). Development of RNA binding proteins expression signature for prognosis prediction in gastric cancer patients.. PubMed. 12(10). 6775–6792. 9 indexed citations
15.
Lin, Xin, Chuan Liu, Fei Zeng, et al.. (2020). Methionine represses the autophagy of gastric cancer stem cells via promoting the methylation and phosphorylation of RAB37. Cell Cycle. 19(20). 2644–2652. 15 indexed citations
16.
Zhou, Qi, et al.. (2020). The renin–angiotensin system blockers and survival in digestive system malignancies. Medicine. 99(7). e19075–e19075. 19 indexed citations
17.
Lin, Xin, Qi Zhou, Yi‐Wu Yuan, et al.. (2019). METase/lncRNA HULC/FoxM1 reduced cisplatin resistance in gastric cancer by suppressing autophagy. Journal of Cancer Research and Clinical Oncology. 145(10). 2507–2517. 70 indexed citations
18.
Lin, Xin, Li Liu, Chuan Liu, et al.. (2019). DNA‐methylation‐mediated silencing of miR‐7‐5p promotes gastric cancer stem cell invasion via increasing Smo and Hes1. Journal of Cellular Physiology. 235(3). 2643–2654. 50 indexed citations
19.
Lin, Xin, et al.. (2018). METase promotes cell autophagy via promoting SNHG5 and suppressing miR-20a in gastric cancer. International Journal of Biological Macromolecules. 122. 1046–1052. 26 indexed citations
20.
Tang, Xu, et al.. (2017). The clinical relationship between the slug-mediated Puma/p53 signaling pathway and radiotherapy resistance in nasopharyngeal carcinoma.. PubMed. 21(5). 953–958. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026